270 related articles for article (PubMed ID: 29391455)
41. The utility of fFN for the prediction of preterm birth in twin gestations.
Ruiz RJ; Fullerton J; Brown CE
J Obstet Gynecol Neonatal Nurs; 2004; 33(4):446-54. PubMed ID: 15346670
[TBL] [Abstract][Full Text] [Related]
42. The utility of fetal fibronectin in asymptomatic singleton and twin pregnancies with a cervical length ≤ 10 mm.
Zork N; Gulersen M; Mardy A; Pessel C; Brubaker S; Vink J; Gyamfi-Bannerman C; Ananth CV
J Matern Fetal Neonatal Med; 2020 Sep; 33(17):2865-2871. PubMed ID: 30572777
[No Abstract] [Full Text] [Related]
43. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery.
Tekesin I; Wallwiener D; Schmidt S
J Perinat Med; 2005; 33(5):383-91. PubMed ID: 16238532
[TBL] [Abstract][Full Text] [Related]
44. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
Incerti M; Ghidini A; Korker V; Pezzullo JC
Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
[TBL] [Abstract][Full Text] [Related]
45. Comparison of Fetal Fibronectin and Phosphorylated Insulin-Like Growth Factor Binding Protein-1 Testing to Predict Preterm Delivery in Symptomatic Women: A 10-Year Retrospective Study.
Chen MX; Dansereau J; Hoag GN
J Obstet Gynaecol Can; 2020 Aug; 42(8):971-976. PubMed ID: 32345553
[TBL] [Abstract][Full Text] [Related]
46. The value of combined cervical length measurement and fetal fibronectin testing to predict spontaneous preterm birth in asymptomatic high-risk women.
Bolt LA; Chandiramani M; De Greeff A; Seed PT; Kurtzman J; Shennan AH
J Matern Fetal Neonatal Med; 2011 Jul; 24(7):928-32. PubMed ID: 21190414
[TBL] [Abstract][Full Text] [Related]
47. Combined insulin-like growth factor binding protein-1/interleukin-6 (Premaquick) versus fetal fibronectin for predicting preterm delivery among women with preterm contractions.
Asiegbu AC; Eleje GU; Ibeneme EM; Onyegbule OA; Chukwu LC; Egwim AV; Okonko CO; Eze SC; Eke AC
Int J Gynaecol Obstet; 2020 May; 149(2):171-177. PubMed ID: 32090329
[TBL] [Abstract][Full Text] [Related]
48. Performance of cervical phIGFBP-1 test alone or combined with short cervical length to predict spontaneous preterm birth in symptomatic women.
Fuchs F; Houllier M; Leparco S; Guyot A; Senat MV; Fernandez H
Sci Rep; 2017 Sep; 7(1):10856. PubMed ID: 28883617
[TBL] [Abstract][Full Text] [Related]
49. Quantitative fetal fibronectin for prediction of preterm birth in asymptomatic twin pregnancy.
Kuhrt K; Hezelgrave-Elliott N; Stock SJ; Tribe R; Seed PT; Shennan AH
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1191-1197. PubMed ID: 32249408
[TBL] [Abstract][Full Text] [Related]
50. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis.
Boots AB; Sanchez-Ramos L; Bowers DM; Kaunitz AM; Zamora J; Schlattmann P
Am J Obstet Gynecol; 2014 Jan; 210(1):54.e1-54.e10. PubMed ID: 24021995
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of quantitative fFn test in predicting the risk of preterm birth.
Centra M; Coata G; Picchiassi E; Alfonsi L; Meniconi S; Bini V; Di Tommaso MR; Cozzolino M; Facchinetti F; Ferrari F; Gervasi MT; Rusconi S; Todros T; Frisina V; Rizzo N; Bisulli M; Di Renzo GC
J Perinat Med; 2017 Jan; 45(1):91-98. PubMed ID: 27049613
[TBL] [Abstract][Full Text] [Related]
52. [Sequential use of cervical length measurement before fetal fibronectin detection to predict spontaneous preterm delivery in women with preterm labor].
Deplagne C; Maurice-Tison S; Coatleven F; Vandenbossche F; Horovitz J
J Gynecol Obstet Biol Reprod (Paris); 2010 Nov; 39(7):575-83. PubMed ID: 20884131
[TBL] [Abstract][Full Text] [Related]
53. The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients.
Skoll A; St Louis P; Amiri N; Delisle MF; Lalji S
J Obstet Gynaecol Can; 2006 Mar; 28(3):206-213. PubMed ID: 16650359
[TBL] [Abstract][Full Text] [Related]
54. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
Peláez LM; Fox NS; Chasen ST
J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
[TBL] [Abstract][Full Text] [Related]
55. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin.
Asakura H; Fukami T; Kurashina R; Tateyama N; Doi D; Takeshita T
Gynecol Obstet Invest; 2009; 68(1):1-8. PubMed ID: 19321961
[TBL] [Abstract][Full Text] [Related]
56. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
[TBL] [Abstract][Full Text] [Related]
57. Clinical Application of Quantitative Foetal Fibronectin for the Prediction of Preterm Birth in Symptomatic Women.
Radford SK; Da Silva Costa F; Araujo Júnior E; Sheehan PM
Gynecol Obstet Invest; 2018; 83(3):285-289. PubMed ID: 29183020
[TBL] [Abstract][Full Text] [Related]
58. Multiple gestations and preterm birth.
Fuchs F; Senat MV
Semin Fetal Neonatal Med; 2016 Apr; 21(2):113-20. PubMed ID: 26795885
[TBL] [Abstract][Full Text] [Related]
59. Comparison of rapid bedside tests for phosphorylated insulin-like growth factor-binding protein 1 and fetal fibronectin to predict preterm birth.
Tripathi R; Tyagi S; Mala YM; Singh N; Pandey NB; Yadav P
Int J Gynaecol Obstet; 2016 Oct; 135(1):47-50. PubMed ID: 27388033
[TBL] [Abstract][Full Text] [Related]
60. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor.
van Baaren GJ; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HCJ; Spaanderman MEA; Bloemenkamp KWM; Haak MC; Bax CJ; Cornette JMJ; Duvekot JJ; Nij Bijvanck BWA; van Eyck J; Franssen MTM; Sollie KM; Vandenbussche FPHA; Woiski M; Bolte AC; van der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ
Ultrasound Obstet Gynecol; 2018 May; 51(5):596-603. PubMed ID: 28370518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
